• FDA issues Covid-19 vaccine guidance as White House reportedly relents

    14 days ago - By MedCity News

    The guidance calls for a median two months' worth of follow-up safety data from well-designed Phase III studies as a precondition for a vaccine receiving an EUA. The Wall Street Journal reported that the White House had backed down in its opposition to the guidance, which pushes the date of an EUA past Election Day.
    Read more ...